Abstract: In various embodiments, a wound dressing includes a wound treatment composition including at least one absorbent or adsorbent compound contained within a sheath having an operatively inner and an operatively outer wall. A surface of the operatively inner wall of the wound dressing, that is to contact a wound in use, is a substantially smooth continuous surface conveniently of a plastic inner wall, selected for easy release from a wound. The inner wall is perforated to enable exudates or slough to pass therethrough. In some embodiments, a wound treatment composition includes an absorbent material, preferably silica, for adsorbing moisture on or around a wound and a collagen, conveniently gelatin.

Abstract: A wound dressing is provided comprising a wound treatment composition (1) including at least one absorbent or adsorbent compound contained within a sheath having an operatively inner and an operatively outer wall (5, and 6 respectively). The wound dressing is characterized in that the surface of the operatively inner wall that is to contact a wound in use is a substantially smooth continuous surface, conveniently of a plastic inner wall, selected for easy release from a wound. The inner wall is perforated (7) to enable exudate or slough to pass therethrough. The invention also provides a wound treatment composition characterized in that it comprises, in combination, an adsorbent material, preferably silica, for adsorbing moisture on or around a wound; and, a collagen, conveniently gelatin.

Abstract: This invention relates to a pharmaceutical composition for use in treating an abnormal skin condition, such as a wound, a burn or a blister, in an animal or human. The pharmaceutical composition has an antiseptic or antimicrobial agent and a desiccant for adsorbing moisture or liquid, in and around the area of the abnormal skin, in a form such that the adsorbed moisture or liquid is not readily available to the skin.